Soligenix's HyBryte™ Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding

5 hours ago

1. Homepage
2. News
3. Soligenix's HyBryte™ Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding